<DOC>
	<DOC>NCT00636948</DOC>
	<brief_summary>The hypothesis of the present trial was that the use of a defunctioning loop stoma reduces the rate of symptomatic anastomotic leakage from 15% to 7.5% after low anterior resection of the rectum for cancer.</brief_summary>
	<brief_title>Rectal Cancer Trial On Defunctioning Stoma</brief_title>
	<detailed_description>The assumption that a defunctioning loop stoma reduces symptomatic anastomotic leakage from 15% to 7.5%, with a level of statistical significance of 5% and a statistical power of 80%, requires randomization of 220 patients.</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Absence of intraoperative adverse events according to the study protocol and the operating surgeon. Presence of intraoperative adverse events according to the study protocol and the operating surgeon.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Rectal cancer surgery</keyword>
	<keyword>Symptomatic anastomotic leakage</keyword>
	<keyword>Defunctioning stoma</keyword>
	<keyword>TME surgery</keyword>
</DOC>